PUBLIC CONTRACT · 2021
MEDICAMENTO EXCLUSIVO BOEHRINGER INGELHEIM PORTUGAL, LDA (UNILFARMA,LDA) - IDARUCIZumab 2500 mg 50 ml sol inj IV
- Contract value
- €12,048.00
- Signed on
- 29 June 2021
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7866751PUBLISHED DESCRIPTION
AD/00000010/2021
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal; Portugal, Aveiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- BOEHRINGER INGELHEIM PORTUGAL, LDA · Tax ID 500293023
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €12,048.00
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 27 September 2021
- Award date
- 11 June 2021
- Signing date
- 29 June 2021
- Performance period
- 212 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33621000-9 - Medicamentos para o sangue e para os órgãos hematopoiéticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5315775
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.